Safety of TJ101 for advanced solid tumors
Part of Cancer, Digestive system, Kidney & urinary, Lungs & breathing clinical trials.
This trial tests a new drug called TJ101 for people with advanced solid tumors who have tried standard treatments or have no standard options. It aims to see if the drug is safe and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor that has spread or cannot be removed, and you have tried standard treatments or none are available.
- You have at least one tumor that can be measured on scans.
- You are 18 years or older.
- You are in generally good health (able to do daily activities) with adequate organ function.
- You have not been treated with certain prior drugs like topotecan, irinotecan, or some antibody-drug conjugates.
- You do not have uncontrolled heart disease, active infections, or certain other medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called AGX101 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it can shrink tumors or slow their growth.
This trial tests a new drug called NP-101 for people with advanced solid tumors that have not responded to standard treatments. It aims to find the safest dose and see if it can shrink tumors.
This trial tests a new drug called TGW101 for people with certain advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and may help shrink tumors.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests a new drug called TMT101 for people with advanced pancreatic cancer or non-small cell lung cancer who have already tried other treatments. The goal is to see if TMT101 is safe and works against the cancer.
This trial tests a combination of a targeted therapy (JMT101) with chemotherapy for a type of lung cancer called squamous cell non-small cell lung cancer that has a specific marker (EGFR). It is for patients whose cancer has gotten worse after prior immunotherapy and chemotherapy.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.